Apogee Acquisition Corp SEC filings AACPU
Apogee Acquisition Corp has 43 filings in SEC EDGAR's recent list, going back to Dec 23, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 20, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (restatement, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Notification of late filing | Aug 14, 2026 | Jun 30, 2026 |
| EFFECT | Filing | Apr 6, 2026 | — |
| CERT | Filing | Apr 6, 2026 | — |
| 8-A12B | For registration of certain classes | Apr 6, 2026 | — |
| CORRESP | Letter to the SEC | Apr 2, 2026 | — |
| CORRESP | Letter to the SEC | Apr 2, 2026 | — |
| CORRESP | Letter to the SEC | Mar 26, 2026 | — |
| CORRESP | Letter to the SEC | Mar 26, 2026 | — |
| CORRESP | Letter to the SEC | Mar 24, 2026 | — |
| CORRESP | Letter to the SEC | Mar 24, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| DRS | Filing | Dec 23, 2025 | — |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- AACP (Nasdaq), AACPR (Nasdaq), AACPU (Nasdaq), AACPW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Cheyenne, WY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2102123
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.